Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

[Vitamine K antagonists overdose: Physician adherence to the French guidelines].

Oliosi E, Pointeau O, Mazoyer E, Le Jeune S, Giroux-Leprieur B, Dhôte R, Mourad JJ.

Rev Med Interne. 2018 May;39(5):321-325. doi: 10.1016/j.revmed.2018.02.019. Epub 2018 Mar 14. French.

PMID:
29550092
2.

Impact of a pneumatic tube system transport on hemostasis parameters measurement: the experiment of Cochin universitary hospital (AP-HP, Paris, France).

Calmette L, Ibrahim F, Gouin I, Horellou MH, Mazoyer É, Fontenay M, Flaujac C.

Ann Biol Clin (Paris). 2017 Feb 1;75(1):93-100. doi: 10.1684/abc.2016.1215. Review.

PMID:
28132949
3.

PT, aPTT, TT and the hemostatic safety threshold of dabigatran and rivaroxaban.

Ibrahim F, Calmette L, Layka A, Horellou MH, Mazoyer É, Gouin-Thibault I, Flaujac C.

Ann Biol Clin (Paris). 2016 Aug 1;74(4):457-64. doi: 10.1684/abc.2016.1173.

PMID:
27492699
4.

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations.

Godier A, Martin AC, Leblanc I, Mazoyer E, Horellou MH, Ibrahim F, Flaujac C, Golmard JL, Rosencher N, Gouin-Thibault I.

Thromb Res. 2015 Oct;136(4):763-8. doi: 10.1016/j.thromres.2015.08.006. Epub 2015 Aug 14.

PMID:
26319422
5.

Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia Screening.

Siguret V, Emmerich J, Belleville T, Golmard JL, Mazoyer E, Gouin-Thibault I, Pautas E.

J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):977-81. doi: 10.1093/gerona/glu240. Epub 2015 Feb 9.

PMID:
25665832
6.

Expanding the scope of metathesis: a survey of polyfunctional, single-site supported tungsten systems for hydrocarbon valorization.

Popoff N, Mazoyer E, Pelletier J, Gauvin RM, Taoufik M.

Chem Soc Rev. 2013 Dec 7;42(23):9035-54. doi: 10.1039/c3cs60115c. Epub 2013 Aug 14.

PMID:
23945666
7.

Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.

De Castro N, Mazoyer E, Porcher R, Raffoux E, Suarez F, Ribaud P, Lortholary O, Molina JM.

Clin Microbiol Infect. 2012 Jun;18(6):E185-7. doi: 10.1111/j.1469-0691.2012.03819.x. Epub 2012 Mar 28.

8.

High selectivity production of propylene from 2-butene: non-degenerate pathways to convert symmetric olefins via olefin metathesis.

Mazoyer E, Szeto KC, Basset JM, Nicholas CP, Taoufik M.

Chem Commun (Camb). 2012 Apr 14;48(30):3611-3. doi: 10.1039/c2cc30172e. Epub 2012 Mar 7.

PMID:
22395285
9.

Development of the first well-defined tungsten oxo alkyl derivatives supported on silica by SOMC: towards a model of WO3/SiO2 olefin metathesis catalyst.

Mazoyer E, Merle N, de Mallmann A, Basset JM, Berrier E, Delevoye L, Paul JF, Nicholas CP, Gauvin RM, Taoufik M.

Chem Commun (Camb). 2010 Dec 21;46(47):8944-6. doi: 10.1039/c0cc02507k. Epub 2010 Oct 27.

PMID:
20981359
10.

Heteronuclear NMR correlations to probe the local structure of catalytically active surface aluminum hydride species on γ-alumina.

Mazoyer E, Trébosc J, Baudouin A, Boyron O, Pelletier J, Basset JM, Vitorino MJ, Nicholas CP, Gauvin RM, Taoufik M, Delevoye L.

Angew Chem Int Ed Engl. 2010 Dec 17;49(51):9854-8. doi: 10.1002/anie.201004310. No abstract available.

PMID:
20886494
11.

Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.

Baran-Marszak F, Magdoud H, Desterke C, Alvarado A, Roger C, Harel S, Mazoyer E, Cassinat B, Chevret S, Tonetti C, Giraudier S, Fenaux P, Cymbalista F, Varin-Blank N, Le Bousse-Kerdilès MC, Kiladjian JJ, Velazquez L.

Blood. 2010 Dec 23;116(26):5961-71. doi: 10.1182/blood-2009-12-256768. Epub 2010 Sep 24.

12.

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels.

Lavigne-Lissalde G, Sanchez C, Castelli C, Alonso S, Mazoyer E, Bal Dit Sollier C, Drouet L, Juhan-Vague I, Gris JC, Alessi MC, Morange PE.

J Thromb Haemost. 2010 May;8(5):942-9. doi: 10.1111/j.1538-7836.2010.03773.x. Epub 2010 Jan 22.

13.

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.

Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L; FITENAT Study Group.

Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. doi: 10.1097/MBC.0b013e32832f5d7a.

PMID:
19730248
14.

Is rituximab effective in acquired von Willebrand syndrome?

Mazoyer E, Fain O, Dhote R, Laurian Y.

Br J Haematol. 2009 Mar;144(6):967-8. doi: 10.1111/j.1365-2141.2008.07538.x. Epub 2008 Dec 12. No abstract available.

PMID:
19120364
15.

Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.

Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L.

Arch Dermatol. 2008 Jul;144(7):861-7. doi: 10.1001/archderm.144.7.861.

PMID:
18645137
16.

Abrupt oxygen decrease influences thrombosis and bleeding in stenosed and endothelium-injured rabbit carotid arteries.

Dellamonica J, Mazoyer E, Rosa JP, Cymbalista F, Samama C.

Eur J Anaesthesiol. 2008 Dec;25(12):1002-8. doi: 10.1017/S0265021508004390. Epub 2008 May 9.

PMID:
18471336
17.

A case report of adenovirus-related acute interstitial nephritis in a patient with AIDS.

Mazoyer E, Daugas E, Verine J, Pillebout E, Mourad N, Molina JM, Glotz D.

Am J Kidney Dis. 2008 Jan;51(1):121-6.

PMID:
18155541
18.

Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients.

Lécureuil C, Combadière B, Mazoyer E, Bonduelle O, Samri A, Autran B, Debré P, Combadière C.

Blood. 2007 May 1;109(9):3649-57. Epub 2006 Dec 29.

19.

Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study.

Mahé I, Bertrand N, Drouet L, Bal Dit Sollier C, Simoneau G, Mazoyer E, Caulin C, Bergmann JF.

Haematologica. 2006 Dec;91(12):1621-7.

20.

Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.

Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM.

J Thromb Haemost. 2007 Feb;5(2):244-9. Epub 2006 Nov 27.

21.

[Digestive surgery and varicose vein surgery].

Steib A, Laporte S, Vailly B, Rohr S, Daudenthun I, Geffroy A, Mazoyer E, Wind P.

Ann Fr Anesth Reanim. 2005 Aug;24(8):890-901. Review. French.

PMID:
16009532
22.

[Thromboelastography: one step forward?].

Salhi F, Mazoyer E, Samama CM.

Ann Fr Anesth Reanim. 2005 Jun;24(6):589-90. French. No abstract available.

PMID:
15921879
23.

Paracetamol: a haemorrhagic risk factor in patients on warfarin.

Mahé I, Bertrand N, Drouet L, Simoneau G, Mazoyer E, Bal dit Sollier C, Caulin C, Bergmann JF.

Br J Clin Pharmacol. 2005 Mar;59(3):371-4.

24.

An unusual cause of renal failure in a liver transplant recipient.

Mazoyer E, Maury E, Fajac A, Carbonell N, Guidet B, Offenstadt G.

J Crit Care. 2004 Sep;19(3):198. No abstract available.

PMID:
15484181
25.

Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosis.

Mazoyer E, Kevorkian JP, Biyick E, Bellucci S, Michalski C, Drouet L.

Blood Coagul Fibrinolysis. 2004 Sep;15(6):519-20. No abstract available.

PMID:
15311163
26.

Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits.

Fattorutto M, Tourreau-Pham S, Mazoyer E, Bonnin P, Raphaël M, Morin F, Cupa M, Samama CM.

Can J Anaesth. 2004 Aug-Sep;51(7):672-9.

PMID:
15310634
27.

Platelet activation and aggregation profile in prolonged external ventricular support.

Houël R, Mazoyer E, Boval B, Kirsch M, Vermès E, Drouet L, Loisance DY.

J Thorac Cardiovasc Surg. 2004 Aug;128(2):197-202.

28.

The effects of a polymerized bovine-derived hemoglobin solution in a rabbit model of arterial thrombosis and bleeding.

Marret E, Bonnin P, Mazoyer E, Riou B, Jacobs T, Coriat P, Samama CM.

Anesth Analg. 2004 Mar;98(3):604-10, table of contents.

PMID:
14980905
29.

Resistance to aspirin after external ventricular assist device implantation.

Houël R, Mazoyer E, Kirsch M, Boval B, Drouet L, Loisance DY.

J Thorac Cardiovasc Surg. 2003 Nov;126(5):1636-7. No abstract available.

30.

[Direct and indirect effects of epoietin alpha in an experimental model of thrombosis and bleeding in the rabbit].

Pham Tourreau S, Fattorutto M, Bonnin P, Mazoyer E, Raphaël M, Morin F, Cupa M, Samama CM.

Ann Fr Anesth Reanim. 2003 Dec;22(10):870-8. French.

PMID:
14644369
31.

Early prediction of the sensitivity of warfarin in elderly patients by the fall in factor VIIc and protein C at the induction of treatment.

Bertola JP, Mazoyer E, Bergmann JF, Drouet L, Simoneau G, Mahé I.

Thromb Res. 2003 Mar 15;109(5-6):287-91. No abstract available.

PMID:
12818252
32.

D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation.

Mahé I, Drouet L, Chassany O, Mazoyer E, Simoneau G, Knellwolf AL, Caulin C, Bergmann JF.

Thromb Res. 2002 Jul 15;107(1-2):1-6.

PMID:
12413581
33.

Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudin.

Mazoyer E, Drouet L, Delahousse B, Gruel Y, Rouyrre N.

Thromb Res. 2002 May 15;106(4-5):271-2. No abstract available.

PMID:
12297138
34.

Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome.

Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L.

Clin Lab Haematol. 2002 Aug;24(4):243-51.

PMID:
12181029
35.

Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers.

Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrières J.

Diabetes Care. 2002 Aug;25(8):1371-7.

PMID:
12145237
36.

Erythropoietin and granulocyte colony-stimulating factor increase plasminogen activator inhibitor-1 release in HUVEC culture.

Stasko J, Drouet L, Soria C, Mazoyer E, Caen J, Kubisz P.

Thromb Res. 2002 Jan 15;105(2):161-4.

PMID:
11958807
37.

Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude.

Mazoyer E, Drouet L, Soria C, Fruchard JC, Pellerin A, Arcan JC, Tobelem G.

Thromb Res. 1999 Aug 15;95(4):163-76.

PMID:
10498386
38.

Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?

Drouet L, Paolucci F, Pasqualini N, Laprade M, Ripoll L, Mazoyer E, Bal dit Sollier C, Vanhove N.

Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S35-9. Review. No abstract available.

PMID:
10070816
39.

[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].

Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L.

Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:41-51. Review. French.

PMID:
9833079
40.

Can high plasma ceruloplasmin levels cause acquired activated protein C resistance?

Ripoll L, Mazoyer E, Baudin B, Lacam S, Varsat B, Drouet LO.

Thromb Haemost. 1998 Feb;79(2):449-50. No abstract available.

PMID:
9493610
41.

Thrombophilia due to 20210 G-->A prothrombin polymorphism and cerebral ischemia in the young.

Bentolila S, Ripoll L, Drouet L, Mazoyer E, Woimant F.

Stroke. 1997 Sep;28(9):1846-7. No abstract available.

PMID:
9303036
42.

Different contribution of factor V Leiden-associated hypercoagulability to ischaemic cerebrovascular disease in the elderly.

Ripoll L, Mazoyer E, Woimant F, Drouet LO.

Blood Coagul Fibrinolysis. 1997 Jun;8(4):253-4. No abstract available.

PMID:
9199825
43.

Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas.

Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, Taïeb A, Stalder JF, Escande JP.

J Pediatr. 1997 Apr;130(4):631-40.

PMID:
9108863
44.

Extensive pure venous malformations in the upper or lower limb: a review of 27 cases.

Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D.

J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):219-25.

PMID:
9039172
45.

High prevalence of antiphospholipid antibodies in disseminated intravascular coagulation.

Karmochkine M, Mazoyer E, Marcelli A, Boffa MC, Piette JC.

Thromb Haemost. 1996 Jun;75(6):971. No abstract available.

PMID:
8822595
46.

Severe arterial thrombosis in a congenitally factor VII deficient patient.

Escoffre M, zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G, Dupuy E.

Br J Haematol. 1995 Nov;91(3):739-41.

PMID:
8555085
47.

Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion.

Chabance B, Jollès P, Izquierdo C, Mazoyer E, Francoual C, Drouet L, Fiat AM.

Br J Nutr. 1995 Apr;73(4):583-90.

PMID:
7794873
48.

[Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?].

Karmochkine M, Piette JC, Mazoyer E, Wechsler B, Chérin P, Herson S, Godeau P, Boffa MC.

Presse Med. 1995 Feb 4;24(5):267-70. Review. French.

PMID:
7899382
49.

The Anti-aggregating Peptide KRDS Impairs a-granule Release, Whereas RGDS Does Not.

Mazoyer E, Caen JP, Tenza D, Cramer EM.

Platelets. 1995;6(2):91-8. doi: 10.3109/09537109509078449.

PMID:
21043699
50.

How does ticlopidine treatment lower plasma fibrinogen?

Mazoyer E, Ripoll L, Boisseau MR, Drouet L.

Thromb Res. 1994 Aug 1;75(3):361-70. Review.

PMID:
7992249

Supplemental Content

Loading ...
Support Center